Helicobacter zhangjianzhongii sp. nov., isolated from dog feces

Front Genet. 2023 Sep 26:14:1240581. doi: 10.3389/fgene.2023.1240581. eCollection 2023.

Abstract

In 2019, two distinct bacterial isolates were independently isolated from the fecal samples of separate dogs in Beijing, China. These cells exhibit microaerobic, are Gram-negative, motile, and possess a characteristic spiral shape with bipolar single flagellum. They display positive results for the oxidase test while being negative for both catalase and urease. These organisms measure approximately 0.2-0.3 μm in width and 4.5-6 μm in length. The colonies are wet, flat, grey, circular, and smooth with sizes ranging from 1 to 2 mm in diameter after 2 days of growth. However, strains may exhibit variations in size and morphology following extended incubation. Phylogenetic analyses based on the 16S rRNA gene and core genome indicated that these two isolates belong to the genus Helicobacter and formed a robust clade that was remains distinctly separate from currently recognized species. These two isolates shared low dDDH relatedness and ANI values with their closest species Helicobacter canis CCUG 32756T, with these values falling below the commonly cutoff values for strains of the same species. The genomic DNA G + C contents of strain XJK30-2 were 44.93 mol%. Comparing the phenotypic and phylogenetic features between these two isolates and their closely related species, XJK30-2 represents a novel species within the genus Helicobacter, for which the name Helicobacter zhangjianzhongii sp. nov. (Type strain XJK30-2T = GDMCC 1.3695T) is proposed.

Keywords: Helicobacter zhangjianzhongii; antimicrobial susceptibility; genomic characteristics; novel species; phylogenetic analyses.

Grants and funding

Sponsored by the National Key Research and Development Program of China (2021YFC2301000), the Project for Novel Detection Techniques of Bacterial Pathogens (32073), the Enhancement of Comprehensive Monitoring, Prevention, and Control Capabilities for Traditional Infectious Diseases Such as Plague, Cholera, and Brucellosis (102393230020020000002) and the Prevention and Intervention of Bacterial and Fungal Infectious Diseases (102393220020020000031).